- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-CD163
CD163 Polyclonal Antibody for WB, IHC, IF-P, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, porc et plus (2)
Applications
WB, IHC, IF-P, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 16646-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | tissu placentaire humain, tissu splénique de porc | 
| Résultats positifs en IP | tissu placentaire humain, | 
| Résultats positifs en IHC | tissu placentaire humain,  tissu d'amygdalite humain,  tissu hépatique humain,  tissu pulmonaire humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. | 
| Résultats positifs en IF-P | tissu d'amygdalite humain, tissu hépatique humain, tissu placentaire humain | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 | 
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunohistochimie (IHC) | IHC : 1:1000-1:4000 | 
| Immunofluorescence (IF)-P | IF-P : 1:50-1:500 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 1 publications below | 
| WB | See 47 publications below | 
| IHC | See 89 publications below | 
| IF | See 114 publications below | 
Informations sur le produit
16646-1-AP cible CD163 dans les applications de WB, IHC, IF-P, IP, ELISA et montre une réactivité avec des échantillons Humain, porc
| Réactivité | Humain, porc | 
| Réactivité citée | rat, Humain, porc, souris | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Polyclonal | 
| Type | Anticorps | 
| Immunogène | CD163 Protéine recombinante Ag10029 | 
| Nom complet | CD163 molecule | 
| Masse moléculaire calculée | 1156 aa, 125 kDa | 
| Poids moléculaire observé | 130-150 kDa | 
| Numéro d’acquisition GenBank | BC051281 | 
| Symbole du gène | CD163 | 
| Identification du gène (NCBI) | 9332 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par affinité contre l'antigène | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
CD163 is a transmembrane protein which belongs to the scavenger receptor cysteine-rich (SRCR) superfamily. This protein is a scavenger receptor for the hemoglobin-haptoglobin complex and is a marker for monocytes and macrophages. Soluble CD163 (sCD163), as a result of ectodomain shedding during inflammatory activation of macrophages, circulates in blood and has been suggested as a plasma/serum marker for macrophage activity.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for CD163 antibody 16646-1-AP | Download protocol | 
| IHC protocol for CD163 antibody 16646-1-AP | Download protocol | 
| IF protocol for CD163 antibody 16646-1-AP | Download protocol | 
| IP protocol for CD163 antibody 16646-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Mil Med Res Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver disease | ||
| Nat Aging Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer | ||
| J Clin Invest CAP2 promotes gastric cancer metastasis by mediating the interaction between tumor cells and tumor-associated macrophages | ||
| Adv Sci (Weinh) Inflammatory Fibroblast-Like Synoviocyte-Derived Exosomes Aggravate Osteoarthritis via Enhancing Macrophage Glycolysis | ||
| Cell Rep Med Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response | ||
| Nat Commun Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. | 
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
| FH Jaouhara (Verified Customer) (12-05-2023) | Works very well in immunohistochemistry (human cartilage) 
 | 
| FH Kenzo (Verified Customer) (08-29-2023) | Works well by IF on frozen mouse liver tissue sections. 
 | 
| FH Yasuyo (Verified Customer) (05-27-2022) | Works pretty good. 
  | 
| FH Emma (Verified Customer) (11-29-2021) | Works well by IF on FFPE tissue @ 1:100 with a Tris-EDTA antigen retrieval. 
  | 














